Cytochrome P450 2E1 mRNA in the rat prostate: Detection and quantitation by competitive reverse transcription and polymerase chain reaction

Molecular and Cellular Probes

Volumn 12, Issue 5, 1998, Pages 263-271

  Jiang, Y ^a   Kuo, C L ^b   Pernecky, S J ^c   Coon, M J ^b   Piper, W N ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c EASTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

Cytochrome P450 2E1; Gene expression; Polymerase chain reaction (PCR); Procarcinogens; Prostate; Pyridine

Indexed keywords

CYTOCHROME P450; ENVIRONMENTAL CHEMICAL; MESSENGER RNA; PYRIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; METABOLIC ACTIVATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ANIMALIA;

EID: 18344398720     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcpr.1998.0177     Document Type: Article

References (36)

1. 1. Gonzalez, F. J. (1989). The molecular biology of the cytochrome P450s. Pharmacological Reviews 40, 243-88.
2. 2. Guengerich, F. P. (1991). Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology 4, 391-407.
3. 3. Guengerich, F. P. (1988). Roles of cytochrome P450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Research 48, 2946-54.
4. 4. Soderkvist, P., Busk, L., Toftgard, R. & Gustafsson, J. A. (1982). Metabolic activation of promutagenic substances to active mutagens in the rat ventral prostate. The Prostate 4, 319-20.
5. 5. Yang, C. S., Smith, T. J., Hong, J. & Zhou, S. (1994). Kinetics and enzymes involved in the metabolism of nitrosamines. In Nitrosamines and Related N-nitroso Compounds, Chemistry and Biochemistry, (Loeppky, R. N. & Michejda, C. J., eds) pp. 169-178. ACS Symposium Series 553.
6. 5. Yang, C. S., Smith, T. J., Hong, J. & Zhou, S. (1994). Kinetics and enzymes involved in the metabolism of nitrosamines. In Nitrosamines and Related N-nitroso Compounds, Chemistry and Biochemistry, (Loeppky, R. N. & Michejda, C. J., eds) pp. 169-178. ACS Symposium Series 553.
7. 6. Verna, L., Whysner, J. & Williams, G. M. (1996). N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacology Therapeutics 71, 57-81.
8. 7. Raucy, J. L. (1993). Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Critical Reviews in Toxicology 23, 1-20.
9. 8. Guengerich, F. P., Kim, D. H. & Iwasaki, M. (1991). Role of human cytochrome P-450IIE1 in the oxidation of many low molecular weight cancer suspects. Chemical Research in Toxicology 4, 168-79.
10. 9. Miller, E. C. (1978). Some current perspectives on chemical carcinogenesis in humans and experimental animals; Presidential address. Cancer Research 38, 1479-96.
11. 10. Kim, S. G. & Novak, R. F. (1990). Role of P450IIE1 in the metabolism of 3-hydroxypyridine, a constituent of tobacco smoke: redox cycling and DNA strand scission by the metabolite 2,5-dihydroxypyridine. Cancer Research 50, 5333-9.
12. 11. Kim, S. G., Williams, D. E., Schuets, E. G., Guzelian, P. S., & Novak, R. F. (1988). Pyridine induction of cytochrome P450 in the rat: role of P450j (alcohol-inducible form) in pyridine N-oxidation. Journal of Pharmacological Experimental Therapeutics 246, 1175-82.
13. 12. Porter, T. D., Khani, S. C. & Coon, M. J. (1989). Induction and tissue-specific expression of rabbit cytochrome P450 2E1 and 2E2 genes. Molecular Pharmacology 36, 61-5.
14. 13. Menzo, S., Bannarelli, P., Giacca, M., Manzin, A., Varaldo, P. E. & Clementi, M. (1992). Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. Journal of Clinical Microbiology 30, 1752-7.
15. 14. Scadden, D. T., Wang, Z. & Groopman, J. E. (1992). Quantitation of plasma human immunodeficiency virus type I RNA by competitive polymerase chain reaction. Journal of Infections Disease 165, 1119-23.
16. 15. Riedy, M. C., Timm, E. A. & Stewart, C. C. (1995). Quantitative RT-PCR for measuring gene expression. Biotechniques 18, 70-6.
17. 16. Vanden Heuvel, J. P., Tyson, F. L. & Bell, D. A. (1993). Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. Biotechniques 14, 395-8.
18. 17. Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162, 156-9.
19. 18. Hellmold, H., Lamb, J. G., Wyss, A., Gustafsson, J. A. & Warner, M. (1995). Developmental and endocrine regulation of P450 isoforms in rat breast. Molecular Pharmacology 48, 630-8.
20. 19. Wynder, E. L., Mabuchi, K. & Whitmore, W. F., Jr (1971). Epidemiology of cancer of the prostate. Cancer 28, 344-60.
21. 20. Meikle, A. W. & Smith, J., Jr (1990). Epidemiology of prostate cancer. Urologic Clinics of North America 17, 709-18.
22. 21. Pienta, K. J. & Esper, P. S. (1993). Risk factors for prostate cancer. Annals of Internal Medicine 118, 793-803.
23. 22. Van Der Gulden, J. W. J., Verbeek, A. L. M. & Kolk, J. J. (1994). Smoking and drinking habits in relation to prostate cancer. British Journal of Cancer 73, 382-9.
24. 23. Hsing, A. W., McLaughlin, J. K., Hrubec, Z., Blot, W. J. & Fraumeni, J. F., Jr (1991). Tobacco use and prostate cancer: 26-year follow-up of US veterans. American Journal of Epidemiology 133, 437-41.
25. 24. Daniel, H. W. (1993). More stage a prostatic cancers, less surgery for benign hypertrophy in smokers. Journal of Urology 149, 68-72.
26. 25. Hatzkin, H. & Soloway, M. S. (1993). Cigarette smoking: a review of possible associations with benign prostatic hyperplasia and prostate cancer. The Prostate 22, 277-90.
27. 26. Daniell, H. W. (1995). A worse prognosis for smokers with prostate cancer. The Journal of Urology 154, 153-7.
28. 27. Hayes, R. B., Brown, L. M., Schoenberg, J. B., Greenberg, R. S., Silverman, D. T., Schwartz, A. G., Swanson, G. M., Benichou, J., Liff, J. M., Hoover, R. N. & Pottern, L. M. (1996). Alcohol use and prostate cancer risk in US blacks and whites. American Journal of Epidemiology 143, 692-7.
29. 28. Kim, S. G., Shehin, S. E., States, C. & Novak, R. F. (1990). Evidence for increased translational efficiency in the induction of P450IIE1 by solvents: analysis of P450IIE1 mRNA polyribosomal distribution. Biochemical and Biophysical Research Communications 172, 767-74.
30. 29. Koop, D. R. & Tierney, D. J. (1990). Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. BioEssays 12, 429-35.
31. 30. Okey, A. B. (1990). Enzyme induction in the cytochrome P-450 system. Pharmacology Therapeutics 45, 241-98.
32. 31. Umeno, M., Song, B. J., Kozak, C., Gelboin, H. V. & Gonzalez, F. J. (1988). The rat P450IIE1 gene: complete intron and exon sequence, chromosome mapping, and correlation of developmental expression with specific 5′ cytosine demethylation. Journal of Biological Chemistry 263, 4956-62.
33. 32. Eliasson, E., Johansson, I. & Ingelman-Sundberg, M. (1988). Ligand-dependent maintenance of ethanol-inducible cytochrome P450 in primary hepatocyte cell cultures. Biochemical and Biophysical Research Communications 150, 436-43.
34. 33. Song, B. J., Matsunaga, T., Hardwick, J. P., Park, S. S., Veech, R. L., Yang, C. S., Gelboin, H. V. & Gonzalez, F. J. (1987). Stabilization of cytochrome P450j message ribonucleic acid in the diabetic rat. Molecular Endocrinology 1, 542-7.
35. 34. Hong, J., Pan, J., Gonzalez, F. J., Gelboin, H. V. & Yang, C. S. (1987). The induction of specific form of cytochrome P-450 (P-450j) by fasting. Biochemical and Biophysical Research Communications 142, 1077-83.
36. 35. Kim, H., Kim, S. G., Lee, M. Y. & Novak, R. F. (1992). Evidence for elevation of cytochrome P450 2E1 (alcohol-inducible form) mRNA levels in rat kidney following pyridine administration. Biochemical and Biophysical Research Communications 186, 846-53.